Logotype for Hamilton Beach Brands Holding Company

Hamilton Beach Brands Company (HBB) Q4 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Hamilton Beach Brands Holding Company

Q4 2024 earnings summary

16 Dec, 2025

Executive summary

  • Full-year 2024 revenue rose 4.6% to $654.7 million, with Q4 revenue up 3.3% to $213.5 million, driven by higher volume, favorable product mix, and new product launches.

  • Gross margin for 2024 expanded 300 basis points to a record 26%, with Q4 gross margin at 26.1% despite a promotional market environment.

  • Operating profit for 2024 increased 23.1% to $43.2 million, while Q4 operating profit was $23.6 million, down 5.7% year-over-year.

  • Net income for 2024 was $30.8 million ($2.20 per diluted share), up from $25.2 million ($1.80 per share) in 2023, including a $5.7 million negative pension plan termination impact.

  • Strong operating cash flow of $65.4 million enabled a net cash position at year-end, supporting share repurchases and dividends.

Financial highlights

  • Q4 2024 revenue was $213.5 million, up 3.3% year-over-year, with gross profit of $55.8 million and a margin of 26.1%.

  • Q4 operating profit was $23.6 million, compared to $25 million in Q4 2023.

  • Q4 net income was $24 million ($1.75 per diluted share), up from $19.6 million ($1.40 per share) last year, aided by a $4.3 million foreign tax benefit and a change in U.S. tax accounting.

  • SG&A expenses rose to $126.7 million in 2024, mainly from the HealthBeacon acquisition and higher incentive compensation.

  • Interest expense fell to $0.6 million in 2024 from $3.0 million, reflecting lower borrowings and rates.

Outlook and guidance

  • 2025 revenue expected to grow in the mid-single-digit range, outpacing the low single-digit industry growth.

  • Operating profit projected to increase faster than revenue, with gross margins in line with 2024's record level.

  • Significant increase in advertising planned to support growth initiatives, while HealthBeacon SG&A expenses are expected to decrease.

  • Cash flow from operations less investing expected at $40–$50 million for 2025.

  • Tariff mitigation efforts to cover up to 75% of products by end of 2025, with price increases and supplier concessions offsetting impacts.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more